Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Astellas Institute for Regenerative Medicine”

30 pharma patents match "Astellas Institute for Regenerative Medicine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Astellas Institute for Regenerative Medicine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Astellas Institute for Regenerative Medicine” · 30,257 patents in full index Clear search

  1. US 9730962

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  2. US 9649340

    Methods for producing enriched populations of human retinal pigment epithelium cells

    Astellas Institute for Regenerative Medicine · Granted May 16, 2017 · Expires May 11, 2037

    granted
  3. US 9650607

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted May 16, 2017 · Expires May 11, 2037

    granted
  4. US 9617512

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  5. US 9562217

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted
  6. US 9550974

    Derivation of embryonic stem cells

    Astellas Institute for Regenerative Medicine · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted